A new major research project is currently under way at the University of Adelaide, as it receives $3.6 million in Federal Government funding. The project, one of 11 new research projects at the University, aims to pair researchers with the industry to develop a single vaccine for both influenza and pneumonia.
“Right across the world, the influenza virus and the bacterium Streptococcus pneumoniae (the pneumococcus) individually cause serious illness and death from acute respiratory infections. However, these two pathogens can also combine and synergise with each other to create a deadly super-infection,” says Professor Paton, who is Director of the University’s Research Centre for Infectious Diseases.
“For example, more than half of the 50 million deaths that occurred during the 1918-19 flu pandemic were directly attributable to pneumococcal super-infection.”
Professor Paton and his colleagues aim to develop a single vaccine capable of providing broad-based protection against both of these pathogens, where “the plan here is to hit both of the things that are going to cause trouble simultaneously in the one vaccine.”
More on this project, can be found here
For more on the flu, take a look at:
Vaccine development in the Russian Federation here
The link between seasonal influenza vaccine production and pandemic readiness here